"Innovative End-to-End Solutions for Phase 1 Clinical TrialsClinical trial complexity has strikingly escalated during the last decades, including a surge in the number of performed procedures, associated costs, and administrative load. Phase 1 clinical trials pose an especially significant challenge due to the requirements for extensive safety monitoring and correlative testing and the high failure rate of developmental drug candidates. BioPharma Services Inc. offers end-to-end solutions for Phase 1 clinical trials ranging from clinical trial design and execution to data reporting and tabulation and the preparation of a final Clinical Study Report. In addition, we have niche expertise in a number of study areas."

During the past decade, BioPharma Services Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BioPharma Services Inc." #1 sponsor was "Ionis Pharmaceuticals, Inc." with 3 trials, followed by "Actelion" with 1 trials sponsored, "Becton, Dickinson and Company" with 1 trials sponsored, "Fresenius Kabi" with 1 trials sponsored and "PhaseBio Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "BioPharma Services Inc." are "Healthy" (2 trials), "Healthy Volunteers" (2 trials), "ADHD" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "BioPharma Services Inc." in a lesser frequency.

Most popular intervention types in "BioPharma Services Inc." are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "4 mm x 32G pen needle (Nano)" (1 trials), "8mm x 31G pen needle (Short)" (1 trials), "ADAIR 10mg IR capsules" (1 trials) and "Aspirin (ASA) Oral Tablet - Pre-Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "BioPharma Services Inc." are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "BioPharma Services Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in BioPharma Services Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BioPharma Services Inc., 7 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".